Empowered Funds LLC raised its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 10.7% during the third quarter, according to its most recent disclosure with the Securities and Exchange ...
Edwards categorizes its therapies and technologies into four categories: Transcatheter Aortic Valve Replacement ("TAVR"), Transcatheter Mitral and Tricuspid Therapies ("TMTT"), Surgical Structural ...
Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Edwards To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in ...